Cargando…
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
BACKGROUND: Metabolic dependencies of chronic lymphocytic leukaemia (CLL) cells may represent new personalized treatment approaches in patients harbouring unfavourable features. METHODS: Here, we used untargeted metabolomics and lipidomics analyses to isolate metabolomic features associated with agg...
Autores principales: | Nguyen Van Long, Flora, Valcourt‐Gendron, Délya, Caron, Patrick, Rouleau, Michèle, Villeneuve, Lyne, Simonyan, David, Le, Trang, Sergerie, Roxanne, Laverdière, Isabelle, Vanura, Katrina, Guillemette, Chantal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689972/ https://www.ncbi.nlm.nih.gov/pubmed/38037464 http://dx.doi.org/10.1002/ctm2.1442 |
Ejemplares similares
-
Inactivation of Prostaglandin E(2) as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia
por: Allain, Eric P., et al.
Publicado: (2019) -
Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
por: Guillemette, Chantal, et al.
Publicado: (2020) -
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
por: Wagner, Antoine, et al.
Publicado: (2023) -
UGT2B17 modifies drug response in chronic lymphocytic leukaemia
por: Allain, Eric P., et al.
Publicado: (2020) -
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients
por: Allain, Eric P., et al.
Publicado: (2018)